Company profile

Frontera

Clinical Documentation & Workflow

Company profile

About Frontera

Frontera Health is a healthcare AI company revolutionizing early intervention care for children with autism and related developmental disorders. The company develops AI-assisted clinical documentation tools specifically designed for Applied Behavior Analysis (ABA) practitioners and clinical psychologists. Their flagship products include Assessment Builder, which helps BCBAs create comprehensive treatment plans and assessment reports in 2-3 hours instead of 6-10 hours, and Diagnosis Builder, which enables clinicians to produce insurance-ready diagnostic reports in half the typical time. The platform leverages advanced AI to analyze unstructured data from clinical notes, intake forms, video recordings, and voice data through what they call 'digital phenotyping.' Frontera's technology is built on proprietary prompt engineering frameworks developed with clinical experts and validated in real-world settings at their owned and operated ABA clinics across rural New Mexico. The company's mission centers on addressing the critical shortage of behavioral health specialists and reducing waitlists that can exceed one year, particularly in underserved rural areas. By streamlining clinical documentation, Frontera enables providers to see more patients, reduce burnout, and accelerate time to treatment for children who need early intervention. Their platform integrates with existing practice management systems and maintains strict HIPAA compliance and data security standards.

Company description Frontera official website

Primary marketClinical Documentation & Workflow
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Frontera?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Autism Spectrum Disorder
  • Behavioral health challenges
  • Developmental disorders
  • Learning disabilities

Who it serves

  • ABA clinics
  • ABA practitioners
  • Autism assessment specialists
  • BCBAs (Board Certified Behavior Analysts)
  • Behavioral health practices
  • Clinical psychologists

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: Various practice management systems (specific names not mentioned).

Geographic context

MarketsRural New Mexico (owned clinics in Clovis, Hobbs, Las Cruces, Roswell, Santa Teresa, Alamogordo) · United States
Company sourceOfficial website

Company milestones

Platform expansion

Operating owned and operated ABA clinics across six locations in rural New Mexico where technology is validated

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Assessment Builder

AI-assisted ABA assessment reporting software for BCBAs

Software · Cloud SaaSCompany source

Diagnosis Builder

AI-assisted diagnosis report builder for clinicians

Software · Cloud SaaSCompany source

Digital Phenotyping

Revolutionary therapy video analysis & advanced behavioral insights

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Corrigendum to "Sex and age differences in alcohol-attributable mortality in Chile between 2008 and 2022" [Public Health Pract. (2026) 100798].

Public health in practice (Oxford, England) · Dec 1, 2026

Vaccinium meridionale Swartz (Agraz): A systematic review of phytochemical composition, extraction technologies, and biological effects.

Food research international (Ottawa, Ont.) · Oct 31, 2026

Methadone treatment and associated health and social outcomes after a national manufacturing closure in Mexico: a longitudinal observational cohort study in Tijuana.

Lancet regional health. Americas · Oct 1, 2026

From forests to deserts: Sequencing of the giant forest hog completes the genomic history of the African suids.

iScience · Sep 18, 2026

Recommendations from the Spanish Society of Medical Oncology to advance the humanization in cancer care.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · Sep 3, 2026

Community-level impacts of low-level diesel exposure on a natural cold-temperate/subarctic phytoplankton assemblage.

Marine pollution bulletin · Sep 3, 2026

Clinical validation

Clinical-trial records

Mama Empoderada: Adapting a Novel Mental Health Prevention Intervention for Migrant Mothers With Young Children

NCT06468046 · Sponsor · COMPLETED

Adduction and Infraspinatus Activity in Shoulder Pain

NCT07765056 · Sponsor · COMPLETED

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

NCT07195695 · Mentioned · RECRUITING

Nutritional Intervention for Older Adults With Complete Dentures

NCT07692828 · Sponsor · NOT YET RECRUITING

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

NCT07242547 · Mentioned · RECRUITING

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07222566 · Mentioned · RECRUITING

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Documentation time reduction from 6-10 hours to 2-3 hours

Assessment report writing for BCBAs

50% reduction in documentation time

Evaluation process for autism assessment specialists

Diagnostic report completion in half the time

Clinical psychologists producing insurance-ready reports

Caitlin Young, M.S., BCBA, LBA

Reducing time spent on treatment plan documentation to allow more time for patient and family interactions

Assessment Builder has been a game-changer, allowing clinician to focus on building relationships while the tool captures essential details

Erin Crawford - EmpowerED Psychological Services

Reducing time spent on assessment report writing

Significantly reduced the amount of time spent on report writing, allowing more time working with students

Haley Golden - AT4K

Reducing documentation time during the evaluation process

Less than 50% of the time spent crafting well-formulated notes that meet the needs of providers, families, and payors

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from Frontera

Recent articles published on Frontera's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Clinical Documentation & Workflow

Companies that use AI to automate clinical documentation, generate medical notes from patient-clinician conversations, or streamline clinical workflows. Includes ambient AI scribes, voice-to-text medical documentation, NLP-powered clinical note generation, and tools that reduce administrative burden on clinicians.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon